PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-7.70%
Negative net income growth while CRWD stands at 31.58%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-2.65%
Negative yoy D&A while CRWD is 8.63%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
206.68%
Some yoy growth while CRWD is negative at -99.19%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-0.15%
Both cut yoy SBC, with CRWD at -26.43%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
135.21%
Less working capital growth vs. CRWD's 1499.89%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
121.20%
AR growth while CRWD is negative at -9.41%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-77.35%
Negative yoy inventory while CRWD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
7900.00%
AP growth of 7900.00% while CRWD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
104.88%
Growth well above CRWD's 165.77%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
125.62%
Well above CRWD's 10.35%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
63.90%
Operating cash flow growth below 50% of CRWD's 721.74%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-6.26%
Both yoy lines negative, with CRWD at -37.67%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-311.25%
Negative yoy acquisition while CRWD stands at 43.14%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
16.31%
Some yoy expansion while CRWD is negative at -6.63%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
20.83%
At 50-75% of CRWD's 37.06%. Martin Whitman questions partial disadvantage if competitor monetizes investments more efficiently.
272.00%
We have some outflow growth while CRWD is negative at -43.14%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
100.84%
Investing outflow well above CRWD's 20.73%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-16566.67%
We cut debt repayment yoy while CRWD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
46.15%
Issuance growth of 46.15% while CRWD is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-35.59%
We cut yoy buybacks while CRWD is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.